High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$4.2M
$4,191,660
Total Sells (Filtered)
$0
$0
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| AKTS |
Aktis Oncology, Inc.
|
Director
Discretionary Buy
|
2026-01-12 | $4,191,660Large | P | Form 4 |